These include BRCA1 (52,53), PCNA (54,55), PLK1 (56,57), MCM2 (58), CHEK2 (59,60), CDK2 (61) and MCM7 (62), suggesting that the network discovered here is likely to be involved in progression of lung cancer. This evidence concerns the gene CHEK2 and lung carcinoma.